Send us a text

Surfing NASH  delivers a session on-site in Vienna to offer a real-time review as EASL Congress 2023 unfolds. This first of two on-site recordings features Ian Rowe, Michael Betel, Jörn Schattenberg and Roger Green as the group digests takeaways from an energized meeting.  Some topics they touch on include Madrigal's MAESTRO-NASH clinical trial of resmetirom, notes around interesting emerging liver science,  the potential role of AI assistance, the NASH therapeutic landscape and many more milestones witnessed by the field since the days of Hep-C.

Listen on to learn more and stay tuned for a Part 2 of this exclusive coverage. If you have any question or interests around the event, we kindly ask that you submit reviews wherever you download the discourse. Alternatively, you can write to us directly at [email protected].

Stay Safe and Surf On!